Recombinant Human Mesothelin-like protein (MSLNL) is produced using a mammalian cell system, which appears to support proper protein folding and post-translational modifications. This partial protein spans amino acids 36 to 638. A C-terminal 10xHis tag has been added to make purification and detection more straightforward. SDS-PAGE analysis confirms purity levels exceeding 95%, which should make it reliable for most research applications.
The Mesothelin-like protein (MSLNL) seems to play a role in cellular processes linked to cell adhesion and signaling. Scientists are still working to understand its complete biological functions, though its structural similarity to mesothelin is well-established. Mesothelin itself is known to be involved in various cellular interactions. Studying MSLNL may help researchers better understand related pathways and mechanisms in human biology.
Potential Applications
Note: The applications listed below are based on what we know about this protein's biological functions, published research, and experience from experts in the field. However, we haven't fully tested all of these applications ourselves yet. We'd recommend running some preliminary tests first to make sure they work for your specific research goals.
Based on the provided information, the folding state and bioactivity of this recombinant MSLNL protein are unknown and cannot be assumed. While the protein is expressed in a mammalian system, which is favorable for proper folding and post-translational modifications, the fact that it is a partial fragment (36-638aa) and carries a C-terminal His-tag introduces uncertainty. The His-tag may potentially interfere with the protein's native structure or function, especially if the C-terminal region is critical for folding or activity. The high purity (>95%) indicates minimal contaminants but does not confirm correct folding or bioactivity. Therefore, any application that relies on the protein's specific biological activity or native conformation is speculative without experimental validation.
1. Antibody Development and Validation Studies
This high-purity recombinant MSLNL protein is suitable for use as an immunogen to generate monoclonal or polyclonal antibodies. The C-terminal His-tag simplifies purification and immobilization for antibody screening. However, since the protein's folding and bioactivity are unverified, antibodies generated may primarily recognize linear epitopes or the His-tag itself. Their ability to bind the natively folded, full-length MSLNL protein in biological systems is not guaranteed and must be empirically validated using native tissue samples or cell lysates. The mammalian expression system increases the likelihood of correct folding, but this remains an assumption without validation.
2. Protein-Protein Interaction Studies
The His-tagged MSLNL protein can be used in pull-down assays to identify potential binding partners. However, the utility of these assays for discovering physiological interactions is entirely contingent on the protein being correctly folded. If the protein is misfolded, it may not present native binding surfaces, leading to non-specific interactions or false negatives. Results from such studies must be interpreted with caution and confirmed with orthogonal methods, such as co-immunoprecipitation using endogenous protein or functional assays.
3. ELISA-Based Quantitative Assays
This purified recombinant MSLNL protein can serve as a standard or coating antigen in ELISA formats. However, its suitability for quantitative detection and measurement of native MSLNL in biological samples is limited. An ELISA built with this reagent may accurately quantify the recombinant human MSLNL protein itself but may not correlate with levels of native, full-length MSLNL due to potential differences in folding, epitope availability, or post-translational modifications. It is best used for detecting antibodies against the immunogen or for quality control of the recombinant protein.
4. Biochemical Characterization and Stability Studies
This high-purity MSLNL protein is well-suited for biochemical characterization, including thermal stability, pH tolerance, and buffer optimization studies. This application is valid as it focuses on the intrinsic physical properties of the protein and does not require native bioactivity. The mammalian expression system may contribute to proper folding, but the data obtained will characterize this specific recombinant form, which may not fully represent the native protein due to the partial length and His-tag.
Final Recommendation & Action Plan
The immediate priority is to validate the protein's folding and bioactivity before proceeding with functional applications. This can be done using techniques such as circular dichroism to assess secondary structure, size-exclusion chromatography to monitor oligomerization, and functional assays (e.g., binding assays with known partners if available) to confirm activity. Once validated, the protein can be reliably used for antibody development (Application 1) and biochemical characterization (Application 4). For interaction studies (Application 2) and quantitative ELISA (Application 3), results should be considered preliminary until confirmed with native protein or functional data. If activity is not confirmed, the protein should be limited to non-functional applications like antibody production (with the noted caveats) and biophysical studies. Always include appropriate controls and validation steps in experiments to ensure data reliability.
